Javascript must be enabled to continue!
A Novel Clinical-Grade Cryopreservation Solution for Adipose Tissue Based on Metformin
View through CrossRef
Abstract
Background
Autologous fat grafting often needs multiple sessions due to low volume retention. Young adipose tissue demonstrates a more pronounced therapeutic effect; thus, the cryopreservation of adipose tissue of young origin is particularly crucial. This study investigated the protective effect of a new cryopreservation solution combining trehalose, glycerol, and metformin on adipose tissue.
Methods
This study initially examined the effect of various concentrations of metformin (0, 1, 2, 4, and 8 mM) on oxidative damage in adipose tissue to identify the optimal concentration. Subsequently, 1.5 mL of fresh human adipose tissue was subjected to freezing using trehalose + glycerol (TG group), trehalose + glycerol + metformin (TGM group), and the common cryoprotectant dimethyl sulfoxide (DMSO) + fetal bovine serum (FBS) (DF group). Samples were cryopreserved in liquid nitrogen for 2 weeks. After thawing, 1 mL of adipose tissue from each group was transplanted subcutaneously into the backs of nude mice. The cryoprotective effects on adipose tissue viability were evaluated during transplantation one month after transplantation.
Results
The 2 mM concentration of metformin exhibited the lowest reactive oxygen species (ROS) level (29.20 ± 1.73) compared to other concentrations (P < 0.05). Cell proliferation and migration assays also supported the superior performance of the 2 mM concentration. Apoptotic analyses of SVF cells also showed the lowest levels in the 2 mM group. Compared to other cryopreservation groups, the adipose tissue in the TGM group closely resembled fresh adipose tissue in terms of gross structure and histological characteristics, with the lowest apoptosis rate of SVF cells. In vivo analysis revealed the highest tissue retention rate in the TGM group, with histological examination indicating robust structural integrity.
Conclusion
The TGM cryopreservation solution, containing metformin, greatly preserves adipose tissue, reduces apoptosis, and improves tissue retention rates. This solution was non-toxic and safe, making it well-suited for tissue cryopreservation in clinical settings.
Springer Science and Business Media LLC
Title: A Novel Clinical-Grade Cryopreservation Solution for Adipose Tissue Based on Metformin
Description:
Abstract
Background
Autologous fat grafting often needs multiple sessions due to low volume retention.
Young adipose tissue demonstrates a more pronounced therapeutic effect; thus, the cryopreservation of adipose tissue of young origin is particularly crucial.
This study investigated the protective effect of a new cryopreservation solution combining trehalose, glycerol, and metformin on adipose tissue.
Methods
This study initially examined the effect of various concentrations of metformin (0, 1, 2, 4, and 8 mM) on oxidative damage in adipose tissue to identify the optimal concentration.
Subsequently, 1.
5 mL of fresh human adipose tissue was subjected to freezing using trehalose + glycerol (TG group), trehalose + glycerol + metformin (TGM group), and the common cryoprotectant dimethyl sulfoxide (DMSO) + fetal bovine serum (FBS) (DF group).
Samples were cryopreserved in liquid nitrogen for 2 weeks.
After thawing, 1 mL of adipose tissue from each group was transplanted subcutaneously into the backs of nude mice.
The cryoprotective effects on adipose tissue viability were evaluated during transplantation one month after transplantation.
Results
The 2 mM concentration of metformin exhibited the lowest reactive oxygen species (ROS) level (29.
20 ± 1.
73) compared to other concentrations (P < 0.
05).
Cell proliferation and migration assays also supported the superior performance of the 2 mM concentration.
Apoptotic analyses of SVF cells also showed the lowest levels in the 2 mM group.
Compared to other cryopreservation groups, the adipose tissue in the TGM group closely resembled fresh adipose tissue in terms of gross structure and histological characteristics, with the lowest apoptosis rate of SVF cells.
In vivo analysis revealed the highest tissue retention rate in the TGM group, with histological examination indicating robust structural integrity.
Conclusion
The TGM cryopreservation solution, containing metformin, greatly preserves adipose tissue, reduces apoptosis, and improves tissue retention rates.
This solution was non-toxic and safe, making it well-suited for tissue cryopreservation in clinical settings.
Related Results
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract
BACKGROUND
Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer agent...
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract
Background: Metformin, an oral biguanide used for the treatment of type-2 diabetes mellitus (DM), has been shown in a considerable number of studies to have...
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract
Introduction and Objective. Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer age...
Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with Type 2 Diabetes: a randomized crossover trial
Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with Type 2 Diabetes: a randomized crossover trial
Abstract
Exercise is recommended in the treatment of Type 2 Diabetes and can improve insulin sensitivity [1]. However, previous evidence suggests that exercise at d...
Vitamin B12 Status in Metformin Treated Diabetics: Cross Sectional Study
Vitamin B12 Status in Metformin Treated Diabetics: Cross Sectional Study
Background: Metformin is the most commonly used drug for patients with type 2 diabetes mellitus (T2DM) patients. Metformin related vitamin B12 deficiency can cause anemia. Accordin...
Human Oocyte Cryopreservation - An Emerging ART Technique: Are We Heading in the Right Direction?
Human Oocyte Cryopreservation - An Emerging ART Technique: Are We Heading in the Right Direction?
Oocyte cryopreservation is a promising adjunct to human assisted reproductive technology. Slow rate freezing has been the cryopreservation standard for storage of sperm, embryos an...
867 Postoperative Metformin is Associated With Improved Survival of Glioblastoma Patients
867 Postoperative Metformin is Associated With Improved Survival of Glioblastoma Patients
INTRODUCTION:
Metformin may improve clinical outcomes for glioblastoma (GBM) patients as metformin showed in vitro tumor suppressor functions, such as reducing the prol...
Exploring the Role of Visceral Fat as a Negative Regulator of Vascular Function In Obesity
Exploring the Role of Visceral Fat as a Negative Regulator of Vascular Function In Obesity
Background and Objective. Obesity promotes endothelial dysfunction, a major contributor to the development of cardiovascular disease. Work from our lab and others previously showed...

